| UniProt ID | ECH1_HUMAN | |
|---|---|---|
| UniProt AC | Q13011 | |
| Protein Name | Delta(3,5)-Delta(2,4)-dienoyl-CoA isomerase, mitochondrial | |
| Gene Name | ECH1 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 328 | |
| Subcellular Localization | Mitochondrion. Peroxisome. | |
| Protein Description | Isomerization of 3-trans,5-cis-dienoyl-CoA to 2-trans,4-trans-dienoyl-CoA.. | |
| Protein Sequence | MAAGIVASRRLRDLLTRRLTGSNYPGLSISLRLTGSSAQEEASGVALGEAPDHSYESLRVTSAQKHVLHVQLNRPNKRNAMNKVFWREMVECFNKISRDADCRAVVISGAGKMFTAGIDLMDMASDILQPKGDDVARISWYLRDIITRYQETFNVIERCPKPVIAAVHGGCIGGGVDLVTACDIRYCAQDAFFQVKEVDVGLAADVGTLQRLPKVIGNQSLVNELAFTARKMMADEALGSGLVSRVFPDKEVMLDAALALAAEISSKSPVAVQSTKVNLLYSRDHSVAESLNYVASWNMSMLQTQDLVKSVQATTENKELKTVTFSKL | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 20 | Phosphorylation | DLLTRRLTGSNYPGL HHHHHHHCCCCCCCE | 36.43 | - | |
| 22 | Phosphorylation | LTRRLTGSNYPGLSI HHHHHCCCCCCCEEE | 28.14 | - | |
| 28 | Phosphorylation | GSNYPGLSISLRLTG CCCCCCEEEEEEEEC | 18.95 | 29496963 | |
| 30 | Phosphorylation | NYPGLSISLRLTGSS CCCCEEEEEEEECCC | 12.22 | 29496963 | |
| 34 | Phosphorylation | LSISLRLTGSSAQEE EEEEEEEECCCCCHH | 28.69 | 30108239 | |
| 36 | Phosphorylation | ISLRLTGSSAQEEAS EEEEEECCCCCHHHC | 19.77 | 30108239 | |
| 37 | Phosphorylation | SLRLTGSSAQEEASG EEEEECCCCCHHHCC | 35.00 | 26657352 | |
| 54 | Phosphorylation | LGEAPDHSYESLRVT CCCCCCCCHHHCEEC | 37.67 | - | |
| 65 | Acetylation | LRVTSAQKHVLHVQL CEECCCCCEEEEEEC | 35.08 | 25825284 | |
| 65 | Ubiquitination | LRVTSAQKHVLHVQL CEECCCCCEEEEEEC | 35.08 | - | |
| 77 | Acetylation | VQLNRPNKRNAMNKV EECCCCCCCCHHHHH | 50.11 | 23749302 | |
| 83 | Acetylation | NKRNAMNKVFWREMV CCCCHHHHHHHHHHH | 26.23 | 25825284 | |
| 83 | 2-Hydroxyisobutyrylation | NKRNAMNKVFWREMV CCCCHHHHHHHHHHH | 26.23 | - | |
| 83 | Ubiquitination | NKRNAMNKVFWREMV CCCCHHHHHHHHHHH | 26.23 | 19608861 | |
| 95 | Acetylation | EMVECFNKISRDADC HHHHHHHHHCCCCCC | 23.08 | 25825284 | |
| 95 | 2-Hydroxyisobutyrylation | EMVECFNKISRDADC HHHHHHHHHCCCCCC | 23.08 | - | |
| 108 | Phosphorylation | DCRAVVISGAGKMFT CCCEEEEECCCHHHH | 15.81 | - | |
| 115 | Phosphorylation | SGAGKMFTAGIDLMD ECCCHHHHCCCCHHH | 22.07 | 22210691 | |
| 139 | Phosphorylation | GDDVARISWYLRDII CCHHHHHHHHHHHHH | 12.24 | 27422710 | |
| 141 | Phosphorylation | DVARISWYLRDIITR HHHHHHHHHHHHHHH | 5.76 | 28111955 | |
| 161 | Acetylation | NVIERCPKPVIAAVH HHHHHCCCCEEEEEC | 56.39 | 26051181 | |
| 186 | Phosphorylation | VTACDIRYCAQDAFF HHHCCHHHHHCCCCC | 7.77 | 28152594 | |
| 196 | Acetylation | QDAFFQVKEVDVGLA CCCCCCEEECCCCEE | 41.03 | 25038526 | |
| 214 | Ubiquitination | GTLQRLPKVIGNQSL HHHHHHCHHHCCHHH | 51.59 | 21890473 | |
| 220 | Phosphorylation | PKVIGNQSLVNELAF CHHHCCHHHHHHHHH | 37.98 | 20068231 | |
| 228 | Phosphorylation | LVNELAFTARKMMAD HHHHHHHHHHHHHHH | 21.68 | - | |
| 231 | Succinylation | ELAFTARKMMADEAL HHHHHHHHHHHHHHH | 30.48 | 27452117 | |
| 231 | 2-Hydroxyisobutyrylation | ELAFTARKMMADEAL HHHHHHHHHHHHHHH | 30.48 | - | |
| 231 | Ubiquitination | ELAFTARKMMADEAL HHHHHHHHHHHHHHH | 30.48 | - | |
| 231 | Malonylation | ELAFTARKMMADEAL HHHHHHHHHHHHHHH | 30.48 | 26320211 | |
| 231 | Acetylation | ELAFTARKMMADEAL HHHHHHHHHHHHHHH | 30.48 | 25038526 | |
| 231 | Succinylation | ELAFTARKMMADEAL HHHHHHHHHHHHHHH | 30.48 | - | |
| 232 | Sulfoxidation | LAFTARKMMADEALG HHHHHHHHHHHHHHH | 1.92 | 21406390 | |
| 240 | Phosphorylation | MADEALGSGLVSRVF HHHHHHHCCHHHHCC | 29.78 | 20068231 | |
| 244 | Phosphorylation | ALGSGLVSRVFPDKE HHHCCHHHHCCCCHH | 27.98 | 20068231 | |
| 250 | Acetylation | VSRVFPDKEVMLDAA HHHCCCCHHHHHHHH | 53.07 | 25038526 | |
| 265 | Phosphorylation | LALAAEISSKSPVAV HHHHHHHHCCCCCEE | 24.18 | 28348404 | |
| 266 | Phosphorylation | ALAAEISSKSPVAVQ HHHHHHHCCCCCEEE | 42.70 | 28348404 | |
| 267 | Acetylation | LAAEISSKSPVAVQS HHHHHHCCCCCEEEE | 52.57 | 12432453 | |
| 268 | Phosphorylation | AAEISSKSPVAVQST HHHHHCCCCCEEEEC | 26.93 | 25849741 | |
| 276 | Ubiquitination | PVAVQSTKVNLLYSR CCEEEECCCEEEECC | 34.08 | 2190698 | |
| 281 | Phosphorylation | STKVNLLYSRDHSVA ECCCEEEECCCCHHH | 12.58 | - | |
| 282 | Phosphorylation | TKVNLLYSRDHSVAE CCCEEEECCCCHHHH | 31.07 | 24719451 | |
| 318 | Ubiquitination | VQATTENKELKTVTF HHHHCCCCEEEEEEE | 59.18 | 19608861 | |
| 318 | 2-Hydroxyisobutyrylation | VQATTENKELKTVTF HHHHCCCCEEEEEEE | 59.18 | - | |
| 318 | Acetylation | VQATTENKELKTVTF HHHHCCCCEEEEEEE | 59.18 | 23749302 | |
| 321 | 2-Hydroxyisobutyrylation | TTENKELKTVTFSKL HCCCCEEEEEEEECC | 41.88 | - | |
| 321 | Ubiquitination | TTENKELKTVTFSKL HCCCCEEEEEEEECC | 41.88 | - | |
| 321 | Acetylation | TTENKELKTVTFSKL HCCCCEEEEEEEECC | 41.88 | 25953088 | |
| 327 | 2-Hydroxyisobutyrylation | LKTVTFSKL------ EEEEEEECC------ | 54.76 | - | |
| 327 | Ubiquitination | LKTVTFSKL------ EEEEEEECC------ | 54.76 | 19608861 | |
| 327 | Acetylation | LKTVTFSKL------ EEEEEEECC------ | 54.76 | 19608861 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ECH1_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ECH1_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ECH1_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| HD_HUMAN | HTT | physical | 15383276 | |
| EF1G_HUMAN | EEF1G | physical | 15383276 | |
| A4_HUMAN | APP | physical | 21832049 | |
| OPA1_HUMAN | OPA1 | physical | 22939629 | |
| HNRL1_HUMAN | HNRNPUL1 | physical | 22939629 | |
| STAT3_HUMAN | STAT3 | physical | 21988832 | |
| EF1D_HUMAN | EEF1D | physical | 21988832 | |
| PEX5_HUMAN | PEX5 | physical | 21988832 | |
| TRAF1_HUMAN | TRAF1 | physical | 25416956 | |
| FAM9B_HUMAN | FAM9B | physical | 25416956 | |
| MCCB_HUMAN | MCCC2 | physical | 26186194 | |
| ECI2_HUMAN | ECI2 | physical | 26186194 | |
| TRAF3_HUMAN | TRAF3 | physical | 26186194 | |
| MCCA_HUMAN | MCCC1 | physical | 26186194 | |
| IQGA1_HUMAN | IQGAP1 | physical | 26186194 | |
| EI2BG_HUMAN | EIF2B3 | physical | 26186194 | |
| FHL2_HUMAN | FHL2 | physical | 26186194 | |
| PTGR3_HUMAN | ZADH2 | physical | 26186194 | |
| SPS1_HUMAN | SEPHS1 | physical | 26344197 | |
| ECI2_HUMAN | ECI2 | physical | 28514442 | |
| TRAF3_HUMAN | TRAF3 | physical | 28514442 | |
| MCCB_HUMAN | MCCC2 | physical | 28514442 | |
| EI2BG_HUMAN | EIF2B3 | physical | 28514442 | |
| MCCA_HUMAN | MCCC1 | physical | 28514442 | |
| FHL2_HUMAN | FHL2 | physical | 28514442 | |
| IQGA1_HUMAN | IQGAP1 | physical | 28514442 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-83; LYS-95; LYS-318 ANDLYS-327, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-28 AND SER-30, AND MASSSPECTROMETRY. | |